Netanyahu: “Israel became the lab for Pfizer”

Video has surfaced of Israeli Prime Minister Benjamin Netanyahu apparently admitting he convinced Pfizer CEO Albert Bourla to give Israel COVID vaccines ahead of every other country.

Netanyahu: “Israel became the lab for Pfizer”

Because 98% of the Israeli population is registered in a digital medical database, Netanyahu claims Israel was able to become “the lab for Pfizer.” 

According to Wide Awake Media, the interview segment was originally from Jordan B. Peterson’s interview with Netanyahu titled “Does Israel have the right to exist? | PM-Elect Benjamin Netanyahu | EP 311.” 

However, Wide Awake Media alleges that the clip of Netanyahu speaking about Pfizer was scrubbed from the version of the video posted on YouTube.

In the three minute clip, Netanyahu brags about doing well on COVID management because of the digital ID that allowed him to convince Bourla to give Israel mRNA vaccines ahead of other countries.

“I persuaded him to give tiny Israel the necessary vaccines to get us out first from COVID,” he said.

“And the reason I could do that is because we have a database. 98%, a medical database, 98% of our population has digitized medical records, a little card, and anywhere you go, and any hospital in Israel, north, south, doesn’t make any difference, boom, punch it in, and you know everything about this patient for the last twenty years.”

Netanyahu proudly speculates what such a detailed medical database would be able to provide to Pfizer, seemingly without concern for the fact that he’s proudly using his citizens as guinea pigs. 

“What does it do to people with meningitis? What does it do to people with high blood pressure? You want to know that. So Israel became, if you will, the lab for Pfizer. And that’s how we did it. We gave the information to the world.” 

Moreover, Netanyahu said in the interview that he intends to add DNA to his already extensive medical digital database. 

“Now let Pharma companies, let medical companies, let them run algorithms on this database — okay? I’m telling you right away they’ll give preference for a few years to Israeli firms, and then to the world.”

“But you can create a biotechnological industry that is unimagined right now.”

As for how he intends to get DNA data from Israeli citizens, he said he thinks they’ll volunteer.

“Give me a saliva sample, volunteer….I’m sure most people will do it, maybe we’ll pay them.”

Share this story

Donate now to keep us on the front lines:

Help Keep your News Free

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

[wpp limit=6 order_by='views']

YOU MIGHT ALSO LIKE THESE...

Trending News

Pfizer sued by Kansas Attorney General: “Pfizer made multiple misleading statements to deceive the public about its vaccine…”

Mike Campbell

June 28, 2024

Trending News

According to an Innovative Research Group poll, while the majority of Canadians (60%) don’t have a strong opinion or feel split on the issue, most still support the free speech of both sides of the conflict.

TCS Wire

June 26, 2024

Trending News

Following intense scrutiny from the mainstream media over a vaccine event hosted by the UCP, pro-vaccine scientists, doctors, and professors opted not to participate in a debate. 

Alexa Posa

June 18, 2024

Trending News

With political tensions rising and an economy in decline, Canadians have formed strong opinions of several countries, many of them negative.

TCS Wire

June 13, 2024

Trending News

Dutch researchers analyzing data from 47 Western countries have postulated that the most likely cause of 3 million excess deaths between 2020 and 2022 is the COVID vaccine.

TCS Wire

June 4, 2024

Trending News

It appears side effects weren’t so rare after all, and AstraZeneca knows it. 

Mike Campbell

May 22, 2024

Want to join the conversation?

Sign up now to be able to like, comment and reply to other members. A full membership to our site includes:

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.